bibliographic resource 5786423 [br/5786423]
https://w3id.org/oc/corpus/br/5786423

is a
title
  • Immunological response and overall survival in a subset of advanced renal cell carcinoma patients from a randomized phase 2/3 study of naptumomab estafenatox plus IFN-α versus IFN-α
publication date
  • 2015-01-01
contributor
format
identifier
part of